122 related articles for article (PubMed ID: 37014013)
1. DNA rehybridization drives product release from Cas9 ribonucleoprotein to enable multiple-turnover cleavage.
Pan J; Mabuchi M; Robb GB
Nucleic Acids Res; 2023 May; 51(8):3903-3917. PubMed ID: 37014013
[TBL] [Abstract][Full Text] [Related]
2.
Yourik P; Fuchs RT; Mabuchi M; Curcuru JL; Robb GB
RNA; 2019 Jan; 25(1):35-44. PubMed ID: 30348755
[TBL] [Abstract][Full Text] [Related]
3. The initiation, propagation and dynamics of CRISPR-SpyCas9 R-loop complex.
Zeng Y; Cui Y; Zhang Y; Zhang Y; Liang M; Chen H; Lan J; Song G; Lou J
Nucleic Acids Res; 2018 Jan; 46(1):350-361. PubMed ID: 29145633
[TBL] [Abstract][Full Text] [Related]
4. Electronic Circular Dichroism of the Cas9 Protein and gRNA:Cas9 Ribonucleoprotein Complex.
Halat M; Klimek-Chodacka M; Orleanska J; Baranska M; Baranski R
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805827
[TBL] [Abstract][Full Text] [Related]
5. Potent CRISPR-Cas9 inhibitors from
Watters KE; Shivram H; Fellmann C; Lew RJ; McMahon B; Doudna JA
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6531-6539. PubMed ID: 32156733
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional insights into the
Zuo Z; Zolekar A; Babu K; Lin VJ; Hayatshahi HS; Rajan R; Wang YC; Liu J
Elife; 2019 Jul; 8():. PubMed ID: 31361218
[TBL] [Abstract][Full Text] [Related]
7. Extensive CRISPR RNA modification reveals chemical compatibility and structure-activity relationships for Cas9 biochemical activity.
O'Reilly D; Kartje ZJ; Ageely EA; Malek-Adamian E; Habibian M; Schofield A; Barkau CL; Rohilla KJ; DeRossett LB; Weigle AT; Damha MJ; Gagnon KT
Nucleic Acids Res; 2019 Jan; 47(2):546-558. PubMed ID: 30517736
[TBL] [Abstract][Full Text] [Related]
8. Efficient Human Genome Editing Using SaCas9 Ribonucleoprotein Complexes.
Wang Y; Wang B; Xie H; Ren Q; Liu X; Li F; Lv X; He X; Cheng C; Deng R; Li J; Zhao J; Song Z; Gu F
Biotechnol J; 2019 Jul; 14(7):e1800689. PubMed ID: 30927491
[TBL] [Abstract][Full Text] [Related]
9. R-loop formation and conformational activation mechanisms of Cas9.
Pacesa M; Loeff L; Querques I; Muckenfuss LM; Sawicka M; Jinek M
Nature; 2022 Sep; 609(7925):191-196. PubMed ID: 36002571
[TBL] [Abstract][Full Text] [Related]
10. Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation.
Campbell LA; Richie CT; Maggirwar NS; Harvey BK
J Neuroimmune Pharmacol; 2019 Dec; 14(4):565-577. PubMed ID: 31172397
[TBL] [Abstract][Full Text] [Related]
11. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
[TBL] [Abstract][Full Text] [Related]
12. Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA.
Liu MS; Gong S; Yu HH; Jung K; Johnson KA; Taylor DW
Nat Commun; 2020 Jul; 11(1):3576. PubMed ID: 32681021
[TBL] [Abstract][Full Text] [Related]
13. Single molecule analysis of effects of non-canonical guide RNAs and specificity-enhancing mutations on Cas9-induced DNA unwinding.
Okafor IC; Singh D; Wang Y; Jung M; Wang H; Mallon J; Bailey S; Lee JK; Ha T
Nucleic Acids Res; 2019 Dec; 47(22):11880-11888. PubMed ID: 31713616
[TBL] [Abstract][Full Text] [Related]
14. Cell-free protein synthesis of CRISPR ribonucleoproteins (RNP).
McGaw C; Chong S
Methods Enzymol; 2021; 659():371-389. PubMed ID: 34752296
[TBL] [Abstract][Full Text] [Related]
15. A thermostable Cas9 with increased lifetime in human plasma.
Harrington LB; Paez-Espino D; Staahl BT; Chen JS; Ma E; Kyrpides NC; Doudna JA
Nat Commun; 2017 Nov; 8(1):1424. PubMed ID: 29127284
[TBL] [Abstract][Full Text] [Related]
16. Cryo-EM structures reveal coordinated domain motions that govern DNA cleavage by Cas9.
Zhu X; Clarke R; Puppala AK; Chittori S; Merk A; Merrill BJ; Simonović M; Subramaniam S
Nat Struct Mol Biol; 2019 Aug; 26(8):679-685. PubMed ID: 31285607
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral Capsid-Mediated
Lu Z; Yao X; Lyu P; Yadav M; Yoo K; Atala A; Lu B
CRISPR J; 2021 Dec; 4(6):914-928. PubMed ID: 33733873
[TBL] [Abstract][Full Text] [Related]
18. Probing the stability of the SpCas9-DNA complex after cleavage.
Aldag P; Welzel F; Jakob L; Schmidbauer A; Rutkauskas M; Fettes F; Grohmann D; Seidel R
Nucleic Acids Res; 2021 Dec; 49(21):12411-12421. PubMed ID: 34792162
[TBL] [Abstract][Full Text] [Related]
19. 5' modifications to CRISPR-Cas9 gRNA can change the dynamics and size of R-loops and inhibit DNA cleavage.
Mullally G; van Aelst K; Naqvi MM; Diffin FM; Karvelis T; Gasiunas G; Siksnys V; Szczelkun MD
Nucleic Acids Res; 2020 Jul; 48(12):6811-6823. PubMed ID: 32496535
[TBL] [Abstract][Full Text] [Related]
20. Cas9 degradation in human cells using phage anti-CRISPR proteins.
Meacham Z; de Tacca LA; Bondy-Denomy J; Rabuka D; Schelle M
PLoS Biol; 2023 Dec; 21(12):e3002431. PubMed ID: 38064533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
